Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's United Therapeutics Corporation (UTHR) position

Yes: as of Q1 2026, Jim Simons holds 1.8M shares of UTHR worth $1.1B (1.7% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$1.1B
Shares held
1.8M
% of portfolio
1.7%
Est. average buy price (i)
$336.31
est. since Q3 2025
Quarter-end price
$592.98

Estimated trade prices

Average price in quarters with purchases
$249.93
Average prices in quarters with sales
  • Q1 2026: $498.02 (122K shares sold)
  • Q4 2025: $465.70 (264K shares sold)
  • Q4 2024: $367.56 (66K shares sold)
  • Q3 2024: $337.80 (19K shares sold)
  • Q1 2024: $225.66 (18K shares sold)
  • Q4 2023: $230.49 (80K shares sold)
  • Q2 2023: $221.53 (40K shares sold)
  • Q1 2023: $246.53 (117K shares sold)
  • Q4 2022: $252.44 (206K shares sold)
  • Q3 2022: $223.56 (243K shares sold)
  • Q1 2022: $190.51 (152K shares sold)
  • Q4 2021: $196.31 (111K shares sold)
  • Q3 2021: $196.97 (82K shares sold)
  • Q2 2021: $190.45 (97K shares sold)

UTHR price vs Simons's position

Dates
$100$200$400$60020222023202420252026Sold 82K shares (2.6%) · Q3 2021. Average closing price $196.97 · Price range $179.86–$214.8882KsharessoldSold 111K shares (3.7%) · Q4 2021. Average closing price $196.31 · Price range $184.32–$216.08111KsharessoldSold 152K shares (5.2%) · Q1 2022. Average closing price $190.51 · Price range $166.16–$213.96152KsharessoldAdded 28K shares (1.0%) · Q2 2022. Average closing price $203.30 · Price range $174.81–$241.1428KsharespurchasedSold 243K shares (8.7%) · Q3 2022. Average closing price $223.56 · Price range $203.30–$244.17243KsharessoldSold 206K shares (8.1%) · Q4 2022. Average closing price $252.44 · Price range $205.95–$280.43206KsharessoldSold 117K shares (5.0%) · Q1 2023. Average closing price $246.53 · Price range $212.99–$276.17117KsharessoldSold 40K shares (1.8%) · Q2 2023. Average closing price $221.53 · Price range $206.86–$232.9940KsharessoldAdded 63K shares (2.9%) · Q3 2023. Average closing price $230.33 · Price range $211.82–$248.2463KsharespurchasedSold 80K shares (3.6%) · Q4 2023. Average closing price $230.49 · Price range $214.88–$256.9480KsharessoldSold 18K shares (0.9%) · Q1 2024. Average closing price $225.66 · Price range $210.76–$249.5118KsharessoldAdded 23K shares (1.1%) · Q2 2024. Average closing price $264.67 · Price range $228.26–$319.0423KsharespurchasedSold 19K shares (0.9%) · Q3 2024. Average closing price $337.80 · Price range $311.04–$363.5519KsharessoldSold 66K shares (3.1%) · Q4 2024. Average closing price $367.56 · Price range $348.65–$410.0066KsharessoldAdded 18K shares (0.8%) · Q1 2025. Average closing price $342.70 · Price range $304.42–$380.7818KsharespurchasedAdded 12K shares (0.6%) · Q2 2025. Average closing price $298.86 · Price range $276.47–$328.4012KsharespurchasedSold 264K shares (12.2%) · Q4 2025. Average closing price $465.70 · Price range $415.34–$517.13264KsharessoldSold 122K shares (6.4%) · Q1 2026. Average closing price $498.02 · Price range $464.93–$592.98122Ksharessold← Earlier —1 sell
Average closing price · filing quarter
$498.02
Price range · filing quarter
$464.93 – $592.98

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −122K −$61M −6.4% 1.8M May 14, 2026
Q4 2025 Reduced −264K −$123M −12.2% 1.9M Feb 12, 2026
Q3 2025 First covered 2.2M Nov 13, 2025
Q2 2025 Added +12K +$3.6M +0.6% 2.1M Aug 13, 2025
Q1 2025 Added +18K +$6.0M +0.8% 2.1M May 14, 2025
Q4 2024 Reduced −66K −$24M −3.1% 2.1M Feb 13, 2025
Q3 2024 Reduced −19K −$6.5M −0.9% 2.2M Nov 13, 2024
Q2 2024 Added +23K +$6.1M +1.1% 2.2M Aug 9, 2024
Q1 2024 Reduced −18K −$4.2M −0.9% 2.2M May 13, 2024
Q4 2023 Reduced −80K −$19M −3.6% 2.2M Feb 13, 2024
Q3 2023 Added +63K +$15M +2.9% 2.3M Nov 14, 2023
Q2 2023 Reduced −40K −$8.9M −1.8% 2.2M Aug 11, 2023
Q1 2023 Reduced −117K −$29M −5.0% 2.2M May 12, 2023
Q4 2022 Reduced −206K −$52M −8.1% 2.3M Feb 13, 2023
Q3 2022 Reduced −243K −$54M −8.7% 2.6M Nov 14, 2022
Q2 2022 Added +28K +$5.8M +1.0% 2.8M Aug 12, 2022
Q1 2022 Reduced −152K −$29M −5.2% 2.8M May 13, 2022
Q4 2021 Reduced −111K −$22M −3.7% 2.9M Feb 11, 2022
Q3 2021 Reduced −82K −$16M −2.6% 3.0M Nov 12, 2021
Q2 2021 Reduced −97K −$19M −3.0% 3.1M Aug 13, 2021
Q1 2021 First covered 3.2M May 13, 2021
Data through Q1 2026 · filed May 14, 2026
21 grouped rows from 21 quarters

Who else owns UTHR

Avoro Capital Advisors LLC

owns 6.2% of shares outstanding
Est. $1.6B · Shares: 2.6M

Wellington Management Group LLP

owns 5.3% of shares outstanding
Est. $1.3B · Shares: 2.3M

Janus Henderson Group PLC

owns 2.0% of shares outstanding
Est. $514M · Shares: 867K

AQR Capital Management LLC

owns 1.9% of shares outstanding
Est. $490M · Shares: 826K

See all owners of UTHR →

More Simons positions

Common questions

Does Jim Simons own UTHR?

Yes. As of Q1 2026, Jim Simons disclosed 1.8M shares of UTHR, worth $1.1B. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy UTHR?

Jim Simons held UTHR since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell UTHR?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in UTHR. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of UTHR does Jim Simons own?

Jim Simons disclosed 1.8M shares of UTHR as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for UTHR?

Jim Simons began building the UTHR position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.